Global Cardiac Pacemaker Market 2022-2028

March 2022 | 77 pages | ID: GB917F55B060EN
Gen Consulting Company

Abstracts

Cardiac pacemakers are smart electronic devices implanted to fix the cardiac arrhythmias. In some situations, pacemakers can defibrillate the heart and improve the pumping function of the weak heart muscles by synchronizing the heartbeats. Garnering a CAGR of 3.1% from 2022 to 2028, the global cardiac pacemaker market is projected to reach worth of USD 4,281 million by 2028-end, according to a new report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global cardiac pacemaker market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the cardiac pacemaker industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, implantability, technology, end user, and region. The global market for cardiac pacemaker can be segmented by product: conventional conditional pacemakers, MRI-conditional pacemakers. The MRI-conditional pacemakers segment held the largest share of the global cardiac pacemaker market in 2021 and is anticipated to hold its share during the forecast period. Cardiac pacemaker market is further segmented by implantability: external pacemakers, implantable pacemakers. Globally, the implantable pacemakers segment made up the largest share of the cardiac pacemaker market. Based on technology, the cardiac pacemaker market is segmented into: cardiac resynchronization therapy pacemakers (CRT-P), dual chamber cardiac pacemakers, single chamber pacemakers. On the basis of end user, the cardiac pacemaker market also can be divided into: ASCs, hospitals, specialty cardiac centers. Cardiac pacemaker market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By product:

• conventional conditional pacemakers
• MRI-conditional pacemakers

By implantability:

• external pacemakers
• implantable pacemakers

By technology:

• cardiac resynchronization therapy pacemakers (CRT-P)
• dual chamber cardiac pacemakers
• single chamber pacemakers

By end user:

• ASCs
• hospitals
• specialty cardiac centers

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The global cardiac pacemaker market report offers detailed information on several market vendors, including Abbott Laboratories, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Galix Biomedical Instrumentation Inc., Lepu Medical Technology (Beijing) Co., Ltd., MEDICO S.R.L., Medtronic plc, MicroPort Scientific Corporation, OSCOR Inc., osypka ag, Shree Pacetronix Ltd., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global cardiac pacemaker market.
• To classify and forecast the global cardiac pacemaker market based on product, implantability, technology, end user, region.
• To identify drivers and challenges for the global cardiac pacemaker market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global cardiac pacemaker market.
• To identify and analyze the profile of leading players operating in the global cardiac pacemaker market.

Why Choose This Report

• Gain a reliable outlook of the global cardiac pacemaker market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Conventional conditional pacemakers
MRI-conditional pacemakers

PART 6. MARKET BREAKDOWN BY IMPLANTABILITY

External pacemakers
Implantable pacemakers

PART 7. MARKET BREAKDOWN BY TECHNOLOGY

Cardiac resynchronization therapy pacemakers (CRT-P)
Dual chamber cardiac pacemakers
Single chamber pacemakers

PART 8. MARKET BREAKDOWN BY END USER

ASCs
Hospitals
Specialty cardiac centers

PART 9. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 10. KEY COMPANIES

Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Galix Biomedical Instrumentation Inc.
Lepu Medical Technology (Beijing) Co., Ltd.
MEDICO S.R.L.
Medtronic plc
MicroPort Scientific Corporation
OSCOR Inc.
osypka ag
Shree Pacetronix Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER